This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: International Society for Drug Development S.r.l.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Simona Sestito: Innovator in Pharmaceutical Development
Introduction
Simona Sestito is a prominent inventor based in Chiaravalle Centrale, Italy. She has made significant contributions to the field of pharmaceutical development, particularly in the area of enzyme inhibitors. Her work focuses on addressing critical health issues, including diabetes and neurodegenerative diseases.
Latest Patents
Simona holds a patent for a compound known as 2-oxo-1,2-dihydropyridine-3-carboxamide. This invention is particularly noteworthy for its potential use as an inhibitor of the PDK1 enzyme. The patent outlines the application of these compounds in treating various pathologies, including Alzheimer's disease, Prion diseases, and certain types of tumors such as breast and pancreatic cancers, as well as glioblastoma.
Career Highlights
Simona is affiliated with the International Society for Drug Development S.r.l., where she applies her expertise in drug development. Her innovative approach has led to advancements in therapeutic options for serious health conditions.
Collaborations
Throughout her career, Simona has collaborated with notable colleagues, including Simona Daniele and Claudia Martini. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Simona Sestito's contributions to pharmaceutical innovation highlight her commitment to improving health outcomes through scientific research. Her work continues to pave the way for new treatments that address critical medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile